NEW YORK (GenomeWeb News) – ATCC on Thursday announced a non-exclusive licensing deal to develop, receive, and distribute biological materials containing Promega's labeling technologies.

The materials from ATCC will contain Promega's NanoLuc, GloSensor, and HaloTag technologies, and the deal covers new and existing products.

"Through this trio of new technologies, ATCC is now better able to [access], develop, and distribute novel products, and deliver new services, which will drive biological research," Brian Pollok, president of ATCC, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.